Our study revealed that elevated AQP9 expression was significantly correlated with aggressive progression, poor survival and immune infiltrations in ccRCC patients, and we validated its prognostic value in a real-world cohort. This evidence concerns the gene AQP9 and nonpapillary renal cell carcinoma.